Who has invested in Athira Pharma?

National Institute on Aging are named among the investors backing Athira Pharma.

Athira Pharma Funding: $289M Raised, IPO (2020)

Athira Pharma funding overview

Athira Pharma is a Biotech company based in Seattle. Athira Pharma has raised $289M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in September 2020. The round record for Athira Pharma runs through 2020; nothing later has been disclosed. Investors on record include National Institute on Aging.

Athira Pharma at a glance

Total raised: $289M
Latest round: IPO
Latest round date: September 2020
Industry: Biotech
Headquarters: Seattle
Notable investors: National Institute on Aging

Frequently asked about Athira Pharma funding

How much has Athira Pharma raised?: Athira Pharma has raised $289M in total disclosed funding across the rounds on record.
Who has invested in Athira Pharma?: National Institute on Aging are named among the investors backing Athira Pharma.
What was the latest Athira Pharma funding round?: The most recent disclosed round is an IPO, announced in September 2020.
Where is Athira Pharma based?: Athira Pharma is based in Seattle.
What sector does Athira Pharma operate in?: Athira Pharma is tracked under Biotech from Seattle, with $289M in disclosed funding.
When did Athira Pharma last raise?: The last disclosed Athira Pharma round closed in September 2020 at IPO.

Round data for Athira Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.

Athira Pharma Funding: $289M Raised, IPO (2020)

Athira Pharma funding overview

Athira Pharma at a glance

Frequently asked about Athira Pharma funding

Companies related to Athira Pharma (37)

Browse related funding lists (5)